Keith Webber is Senior Director of Rx Regulatory Affairs at Perrigo Company. Prior to joining industry, he served at the US FDA in both the CDER and CBER in a variety of roles including Director of the Office of Pharmaceutical Science, Director of the Office of Generic Drugs, Director of the Office of Biotechnology Products. Dr. Webber was a member of the FDA’s negotiating team for the first Generic Drug User Fee Program (GDUFA-I), as well as the industry team that negotiated GDUFA-II.